Good Samaritan Medical Center is the first hospital in South Florida, outside of Miami, to perform Aquablation® therapy with the new HYDROS™ Robotic System, the next-generation AI-powered platform to treat benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. Aquablation therapy was designed to offer a minimally invasive and effective solution for BPH that can be applied to almost all prostate gland sizes. Now delivered by an AI-powered robotic system, Aquablation therapy is clinically proven to provide significant, durable BPH symptom relief while preserving sexual function and continence. Read more here: https://bit.ly/3ERwjOW
Healthcare Technology, Care Delivery, and Equity Investment Opportunities
1moIt's fascinating to see advancements like the HYDROS™ Robotic System being implemented at Good Samaritan Medical Center. The use of AI-powered technology like Aquablation therapy for treating BPH marks a significant step forward in medical treatments, offering patients minimally invasive options with clinically proven outcomes. It's promising to hear about technologies that not only improve health but also maintain quality of life. Looking forward to seeing how this impacts patient care in South Florida and beyond.